Commonwealth Equity Services
MIRA icon

Commonwealth Equity Services’s MIRA Pharmaceuticals MIRA Stock Holding History

Commonwealth Equity Services’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3K Buy
53,189
+18,122
+52% +$18.3K ﹤0.01% 4310
2026
Q1 		$37.5K Buy
35,067
+4,880
+16% +$6.12K ﹤0.01% 4221
2025
Q4 		$45.6K Hold
30,187
– – ﹤0.01% 4190
2025
Q3 		$41K Buy
30,187
+523
+2% +$759 ﹤0.01% 4174
2025
Q2 		$36K Buy
29,664
+4,117
+16% +$4.75K ﹤0.01% 4190
2025
Q1 		$25K Buy
25,547
+10,475
+69% +$11.9K ﹤0.01% 4116
2024
Q4 		$17K Buy
+15,072
New +$19.7K ﹤0.01% 4051

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Commonwealth Equity Services's MIRA Position: Q2 2026 in Review

Commonwealth Equity Services increased its MIRA Pharmaceuticals (MIRA) stake by 52% in Q2 2026, buying an estimated $18.3K and bringing the position to 53,189 shares worth $50.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4310.

Commonwealth Equity Services first reported a position in MIRA in Q4 2024 and has held it in 7 quarters since. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Commonwealth Equity Services held 53,189 shares of MIRA Pharmaceuticals worth $50.3K as of Q2 2026.
  • Commonwealth Equity Services bought 18,122 MIRA Pharmaceuticals shares in Q2 2026, an estimated $18.3K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4310 holding.
  • Commonwealth Equity Services first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.